A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell Lymphoma

Clinical trial NCT01169298 · COMPLETED

Trial details

NCT number: NCT01169298
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Adult T-cell Leukemia-Lymphoma Peripheral T-cell Lymphoma

Start date: 2010-07-01
Primary completion: 2013-12-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.